GLP-1 RECEPTOR AGONISTS IN NEUROLOGICAL DISEASES: MECHANISMS AND THERAPEUTIC PROSPECTS FROM METABOLISM TO NEUROPROTECTION

Descargar Publicación
Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies Obesity and Risk of Pediatric-Onset Multiple Sclerosis (POMS): a Systematic Review and Meta-Analysis.